Team
We are an interdisciplinary team of experts in machine learning, RNA biology, and drug discovery with deep expertise and a relentless focus on results.
We value bold innovation, collaboration, care, and a growth mindset.
We don’t just push boundaries—we redefine them.
We are an interdisciplinary team of experts in machine learning, RNA biology, and drug discovery with deep expertise and a relentless focus on results.
We value bold innovation, collaboration, care, and a growth mindset.
We don’t just push boundaries—we redefine them.
Scientific Advisors
Nicholas Meanwell
Drug Hunter and Medicinal Chemist
- Former Scientific VP of Small Molecule Drug Discovery at Bristol-Myers Squibb.
- Advanced 33 clinical candidates over a 40-year career at BMS.
Amanda Garner
RNA Drug Discovery, Chemistry, and Biology
- Associate Professor of Medicinal Chemistry at the University of Michigan.
- Bridges chemistry and biology to unlock the druggability of RNA.
Gene Yeo
RNA Biology and RNA Therapeutics
- Professor of Cellular and Molecular Medicine at UC San Diego.
- Researches RNA processing and the role of RNA-binding proteins in development and disease.
Ron Dror
Computational Biology and Machine Learning
- Professor of Computer Science, Stanford University.
- Uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function.
Percy Carter
Drug Discovery Leader and Biotech Executive
- Chief Scientific Officer at Blueprint Medicines and Board Member at HiFiBiO Therapeutics.
- Leads multi-disciplinary teams across genomics, molecular
- biology and medicinal chemistry to discover and develop innovative precision medicines for cancer and rare diseases.
Our Investors
